ArticleAmerican journal of translational research2026
Sleep duration inversely correlates with glucolipid metabolism in patients with new-onset type 2 diabetes mellitus.
Article in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo study the correlation between sleep duration and glucolipid metabolism in patients with new-onset type 2 diabetes mellitus (NOT2DM).
methodsThe participants were 168 NOT2DM patients. Glucolipid metabolism indices were compared among the short (n=59), middle (n=56), and long sleep groups (n=53), including fasting blood glucose (FBG), glycosylated hemoglobin (HbA1c), total cholesterol (TC), and triglyceride (TG). The correlation of sleep duration with glucolipid metabolism, glycemic control, and body fat distribution (abdominal total fat area [TFA] and visceral fat area [VFA]) was assessed. Finally, the contributors to poor glycemic control were explored.
resultsGlucolipid metabolism indices tended to decrease with increasing sleep duration in NOT2DM patients, suggesting a significant negative correlation between sleep duration and glucolipid metabolism. The sleep duration of the good glycemic control group was significantly longer. A significant positive correlation was identified between sleep duration and good glycemic control, while an inverse association was determined between sleep duration and TFA. Body mass index (BMI), sleep duration, FBG, TG, and TFA were all independent contributors to poor glycemic control.
conclusionsSleep duration in NOT2DM patients was inversely related to glucolipid metabolism and TFA and positively correlated with good glycemic control. High BMI, FBG, TG, and TFA, as well as short sleep duration, may increase the risk of poor glycemic control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.